BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
Get Our Industry eNewsletter FREE email:    
Biotech/Pharma - Alliances (World)
Athersys, Inc. (ATHX) And Chugai Pharmaceutical Co., Ltd. (Japan) Enter License Agreement And Collaboration To Develop Multistem Cell Therapy For Ischemic Stroke In Japan 3/2/2015
Genmab A/S (GEN.CO) Announces That Agreement To Transfer Ofatumumab Collaboration To Novartis AG (NVS) Is Now Effective 3/2/2015
SCIEX And Labor Berlin Collaboration To Advance Forensic Testing 3/2/2015
Clinigen Group Signs Distribution Agreement With MSD UK For Clinical Trial Supply Services 2/27/2015
Triphase Accelerator Enters Into Academic Center Collaboration With Sunnybrook Research Institute To Advance Development Of Bi-Specific Antibody In The Interest Of Cancer Patients 2/27/2015
Eddingpharm Gains China Rights To Acorda Therapeutics (ACOR)'s Omega-3 Product In $169 Million Deal 2/27/2015
AstraZeneca PLC (AZN) Taps Startup for $122.5 Million Autoimmune Pact 2/26/2015
Vernalis PLC (VNLPY.PK) Licenses Proprietary ARA Technology 2/26/2015
Acceliant Announces Its Partnership With Lupin Pharmaceuticals, Inc. 2/25/2015
The Medicines Patent Pool Signs Licensing Agreement With MSD For Paediatric Formulations Of Raltegravir 2/24/2015
Roche (RHHBY) And BioMed X Collaborate To Develop Nanomaterial-Based Biosensors For Near-Patient Testing 2/24/2015
University of Tubingen And Mediso Enter Into A Collaboration To Develop A Preclinical PET Insert For Simultaneous Acquisition In High Field MRI Systems 2/23/2015
Mylan Inc. (MYL) Signs Exclusive Agreement With Gilead (GILD) To Distribute Sovaldi And Harvoni In India 2/23/2015
Nakashima And Teijin Limited To Establish Joint Venture For Global Expansion Of Japanese-Made Medical Device Business 2/23/2015
The Gene Center At Ludwig-Maximilians-Universität München, Germany And ExpreS2ion Biotechnologies> Enter A Licensing Agreement For Use Of The ExpreS2 Technology Platform 2/23/2015
Georgia State University Out-Licenses Leukemia Drug To China's Cisen Pharma 2/23/2015
Crossbeta Biosciences B.V. To Supply PerkinElmer, Inc. (PKI) Stable Oligomers For Use As AlphaLISA Analytes 2/23/2015
Queen Mary University Of London And Takeda (TKPYY) Announce Research Collaboration To Develop Novel Therapies in Gastroenterology 2/20/2015
Sterigenics International, Inc. And Nordion Announce Landmark Canada-U.S. Partnership Agreement To Provide A Long-Term, Reliable Supply Of Medical Isotopes 2/20/2015
Sanofi (SAN.PA): Deals Like the One Made With Tiny Lead Pharma Will Not Replace In-House R&D 2/19/2015
Bionovion Enters Commercial Immune Oncology Collaboration With Genmab A/S (GEN.CO) 2/19/2015
ErgoMed Announces Co-Development Agreement With Dilaforette For Sickle-Cell Disease Treatment 2/19/2015
Eagle Pharmaceuticals (EGRX), Teva Pharmaceutical Industries (TEVA) Forge $120 Million Leukemia Drug Pact 2/18/2015
Amarantus BioSciences, Inc. Announces First Alzheimer's Biomarker Services Collaboration For Lympro Test With Anavex Life Sciences Corp. (AVXL) 2/18/2015
NYU Langone Medical Center, Technion-Israel Institute Of Technology To Forge Groundbreaking Partnership In Cancer Research 2/18/2015
Immuron Signs Agreement To Sell Travelan In China 2/17/2015
Lupin Ltd. (LUPN.BO) And Celon Announce Strategic Development And Licensing Agreement For Generic Advair Diskus 2/17/2015
WuXi PharmaTech Co., Ltd. Enters Into $165 Million Syndicated Loan Agreement 2/17/2015
Novartis AG (NVS) Eyes Israeli Companies 2/16/2015
Dako A/S (Acquired by Agilent Technologies, Inc.) (A) And Ono Pharmaceutical Company, Ltd. Announce Collaboration On Development Of PD-L1 Companion Diagnostic Test For Investigational Cancer Drug Opdivo(Nivolumab) 2/16/2015
Reproductive Health Science Ltd (ASX:RHS) Signs Two New Distributor Agreements 2/16/2015
TiGenix And Lonza Group Ltd. (LZAGY.PK) Sign Agreement For The Manufacture Of Stem Cell-Based Treatment Of Complex Perianal Fistulas In Crohn's Disease 2/12/2015
BIOCEO15: BioLineRx Ltd. CEO Touts New Celiac Drug, Fleshes Out Novartis AG (NVS) Partnership Terms 2/11/2015
Government Joins Forces With PUP And Xenophon To Stifle Biotech Innovation 2/11/2015
Boehringer Ingelheim Corporation Renews Global Technology Collaboration Agreement With VTU Technology 2/10/2015
SIB Swiss Institute Of Bioinformatics Designated An FAO Reference Centre 2/10/2015
Merck & Co. (MRK) Abandons Highly Visible JV Venture With Simcere Pharmaceutical Group 2/9/2015
CrystalGenomics Partners With Daewoong Pharmaceutical For Acelex Commercialization In Korea 2/9/2015
Helsinn Group Signs Exclusive Agreement With Mundipharma For Distribution And Licensing Of Netupitant/Palonosetron (NEPA) In Brazil 2/9/2015
Moberg Pharma AB (Formerly known as Moberg Derma) Extends Distribution Agreement With Menarini Group For Emtrix To Russia 2/9/2015
Easton Pharmaceuticals (OP: EAPH) Provides Update On Its Medicated Markets Partnership, Joint Initiatives And The Booming Medical Marijuana Climate In California For January 2015 2/9/2015
Tianyin Pharmaceutical Co, Inc. To Form Strategic Alliance With Buchang Pharma 2/6/2015
Cerus Corporation (CERS) And SunCoast Blood Bank Enter Into Agreement For The Use Of INTERCEPT Platelets And Plasma 2/5/2015
TTP LabTech Ltd. And Almac Group’s Strategic Alliance Consolidates Fluorescence Lifetime Technology To Form A One-Stop Shop For Compound Screening 2/5/2015
Biolin Scientific And Nanion Technologies Have Entered Into A Licensing Agreement 2/5/2015
MedImmune (AZN) And The AstraZeneca PLC (AZN) Announce Partnership To Advance Protein Formulation Science 2/5/2015
Isofol Medical AB Appoints The Sage Group To Identify Strategic Partnerships For Its Novel Modufolin® Chemotherapy Asset 2/4/2015
Consort Medical Signs Multi–Year Supply Agreement For Its Proprietary Integrated Dose Counter (IDC) System 2/4/2015
Moderna Therapeutics, Inc. And Institut Pasteur Sign Strategic Research Collaboration 2/3/2015
TEMIS Signs Large License Deal In The Swiss Reinsurance Industry 2/3/2015
Collaboration Between AYOXXA And Singapore Eye Research Institute 2/3/2015
Helsinn Group Grants Stendhal International Exclusive Rights To The Distribution And Marketing Of Netupitant-Palonosetron (NEPA) In Multiple Countries Of Latin America 2/2/2015
Horizon Discovery Group Selected As Core Facility By Tri-Institutional Therapeutics Discovery Institute 2/2/2015
EMD Millipore Announces Agreement With Precision Biologics To Provide Upstream Process Development Services 2/2/2015
NIHR Announces Partnership With Janssen To Investigate Why Current Rheumatoid Arthritis Biological Treatments Fail In A Third Of Patients 2/2/2015
Genticel Licenses Vaxiclase Platform To Serum Institute of India, Ltd. For Use In Pertussis Vaccines 2/2/2015
Mylan Inc. (MYL), Theravance, Inc. (THRX) Partner Up for $265 Million COPD Pact 2/2/2015
AstraZeneca PLC (AZN) Hooks Up With Four Top R&D Institutions for CRISPR R&D 1/30/2015
Roche (RHHBY) and Qualcomm Partner Up for Remote Patient Monitoring 1/30/2015
Fosun Pharma Seeking Hospital Partnership In Heilongjiang Province 1/29/2015
OSE Pharma Appoints Simbec-Orion To Conduct Its Tedopi® Phase 3 International Clinical Trial In Advanced Lung Cancer Patients 1/29/2015
Biogen Idec (BIIB), Fondazione Telethon And Ospedale San Raffaele Announce Global Collaboration To Develop Gene Therapies For Hemophilia 1/29/2015
Merck Selects Credit360 To Manage Sustainability Data Consistently Across Their Global Organization 1/29/2015
MicroConstants China In-Licenses Global Rights Of AA98 Antibody Drug Candidates From Institute Of Biophysics, Chinese Academy Of Sciences 1/29/2015
Symphogen Regains Rights To Sym004 1/29/2015
TxCell Receives EUR 1 Million Milestone Payment Regarding Ovasave® Collaboration Agreement From Trizell 1/29/2015
Merck KGaA (MKGAF.PK) Walks Away From $625 Million Deal With Symphogen A/S 1/29/2015
Cord Blood Registry And China Cord Blood Corporation Enter Into Strategic Collaboration 1/28/2015
Luxembourg Institute Of Health Research Dedicated To Life 1/28/2015
AstraZeneca PLC (AZN) Chooses Box To Power Enterprise Content Collaboration For All Employees 1/27/2015
Prima Biomed (PRR.AX) Release: Financial Milestone Payment To Be Received From GlaxoSmithKline (GSK) 1/27/2015
PreAnalytiX, NuGEN Technologies, Inc. And RUCDR Infinite Biologics Partner To Develop Clinically Validated RNA-Seq Workflow For Whole Blood Samples 1/27/2015
Yissum And Phytotech Medical To Collaborate On Novel Delivery System For Medical Cannabis 1/26/2015
Mylan Inc. (MYL) Expands Hepatitis C Licensing Agreement With Gilead Sciences, Inc. (GILD) To Include Investigational Pan-Genotypic Agent 1/26/2015
With Some Help, GlaxoSmithKline (GSK) Believes They Have Found Cancer's "Achilles Heel" 1/23/2015
Immune Therapeutics, Inc. Announces Agreement With KRS Global Biotechnology, Inc. 1/23/2015
Celgene (CELG) Bets Big on Canada's Zymeworks 1/22/2015
Curis, Inc. (CRIS), Aurigene Discovery Technologies Limited Forge $415 Million+ Immuno-Oncology Pact 1/22/2015
Heptares Technology Enables Breakthrough In Drug Discovery Collaboration With AstraZeneca PLC (AZN) 1/22/2015
ImmuPharma plc (IMM.L) Release: Landmark Collaboration Agreement & Commencement Of Pivotal Phase 3 Lupuzor™ Study With Simbec-Orion Deal Provides Powerful Validation For Lupuzor™ 1/22/2015
New Oncology And University Hospital Oslo Announce Genomic Profiling Collaboration 1/22/2015
Johnson & Johnson (JNJ), Takeda (TKPYY) Open Up Israeli Biotech Incubator to Develop New Cures for Old Ills 1/21/2015
Mitsubishi Gas Forms Asian Biologics CRO Partnership With Catalent 1/21/2015
SYGNIS Signs Distribution Agreement With bioNova cientifica, s.l. For Its Innovative TruePrime™Single Cell WGA Kit In Spain 1/21/2015
Cell Therapy Catapult And Trakcel To Collaborate On Research Project 1/20/2015
Kingworld Medicines Forms Marketing/Distribution Alliance With Sinopharm 1/20/2015
Strides Arcolab Limited Snags Huge HIV Pact With Gilead Sciences, Inc. (GILD) 1/20/2015
VECT-HORUS Announces The Signing Of A Scientific Collaboration Agreement With Sanofi (SAN.PA) 1/19/2015
Evotec AG (EVTG.F) And C4X Discovery Enter Collaboration To Identify Pre-Clinical Development Candidates For Stress-Related Addictive Disorder Programme 1/19/2015
BMG Pharma S.r.l Grants The Exclusive Distribution Rights For Gelx® Oral Gel And Gelx® Spray For The Treatment Of Oral Mucositis In Cancer Patients To Ferrer Internacional 1/19/2015
Solasia Pharma K.K. And Meiji Seika Pharma Announce License And Collaboration Agreement For Darinaparsin (Intravenous Formulation) 1/19/2015
UCB SA, Neuropore to Develop Parkinson's Treatment in $480 Million Deal 1/16/2015
Sanofi (SAN.PA), Boehringer Ingelheim Corporation Forge Biologics Pact 1/15/2015
Evotec AG (EVTG.F) Achieves Further Milestones In TargetAD Collaboration With Janssen Pharmaceutical Inc. 1/15/2015
3SBio Inc. (SSRX) Signs Exclusive Patent License Agreement For DIG-KT, A Bi-Specific mAb Targeting VEGFR2 And Tie-2 With Pharmabcine 1/15/2015
Another Day, Another $750 Million Antibiotic Deal for Roche (RHHBY) 1/14/2015
Tianyin Pharmaceutical Co, Inc. To Form Strategic Alliance With Buchang Pharma 1/14/2015
Oxford BioTherapeutics Grants An Exclusive License To Boehringer Ingelheim For Development And Commercialization Of Antibody Products To An Oncology Target 1/14/2015
Treeway Announces License And Collaboration Agreement With uniQure To Develop A Gene Therapy For Amyotrophic Lateral Sclerosis (ALS) 1/14/2015
National Research Council of Canada And KalGene Pharmaceuticals Announce License Agreement For The Development Of Novel Alzheimer's Therapeutics 1/14/2015
Boehringer Ingelheim Corporation And Vanderbilt University Join Forces To Develop New Ras Inhibitors For Cancer Treatment 1/14/2015
Merck & Co. (MRK) Jumps Into RNA Frenzy With $100 Million Bet on Moderna Therapeutics, Inc. 1/14/2015
Novartis AG (NVS), Qualcomm Launch $100 Million Fund for Innovative Health Startups 1/14/2015
Therapix And Dekel Pharmaceuticals Sign Binding Term Sheet Outlining Licensing And Royalty Agreement 1/13/2015
New Partnership In Russia And CIS Further Expands Footprint For EffRx Proprietary Technologies 1/13/2015
Allegro Ophthalmics LLC And Hanmi Pharmaceutical, Co., Ltd Announce Strategic Investment And Collaboration To Develop And Market Luminate® In The Republic Of Korea And China 1/13/2015
Shanghai Biotech Forms Genomic CRO Alliance With AKESOgen, Inc. 1/13/2015
Esteve S.A. (Laboratorios Del Dr. Esteve S.A.) Could Bank $1 Billion From Mundipharma AG, Purdue Pharma L.P. Pain Pact 1/12/2015
Boehringer Ingelheim Corporation And Yale University Collaborate To Investigate Novel Immunotherapy Targets Across Several Therapeutic Areas 1/12/2015
Precision NanoSystems And Arcus Therapeutics, LLC Announce A Partnership For The Manufacture Of RNA Medicines 1/9/2015
Novartis AG (NVS) Strikes First-of-its-Kind Biotech Deal for Next Generation Drugs 1/9/2015
Incyte Corporation (INCY), Agenus (AGEN) Strike $410 Million+ Immuno-Oncology Antibodies Pact 1/9/2015
Helsinn And Pharmacosmos A/S Enter Into An Exclusive License Agreement For The Development And Commercialization Of Monofer® In US 1/8/2015
BrainStorm Cell Therapeutics Inc. Enters Into Warrant Exercise Agreement For Approximately $13 Million In Proceeds 1/8/2015
MRC Technology To Manage Diabetes UK’s IP 1/8/2015
Proteros biostructures GmbH Enters Into A Collaboration With Bayer To Develop New Cardiovascular Drug Compounds For An Integral Membrane Protein 1/8/2015
Abcam plc (ABC.L) Signs Exclusive Partnership Agreement With A*STAR’s Institute Of Molecular And Cell Biology 1/8/2015
Mexichem Acquires The Distribution And Sale License For HFC-227ea/P Medical Propellant From Dupont Fluorochemicals 1/8/2015
Shenzhen Hybio Pharma Sells US Rights For Generic MS Drug To Akorn, Inc. (AKN) 1/8/2015
Syndax Pharmaceuticals Inc. Snags $125 Million Deal With Kyowa Hakko Kirin 1/8/2015
Evotec AG (EVTG.F) And Padlock Therapeutics Announce Initial Success And Extension Of Long-Term Collaboration 1/7/2015
GenSight Biologics, Pixium Vision And Fondation Voir Et Entendre Join Forces And Benefit From A Total € 18.5 Million Funding For SIGHT AGAIN As Part Of The Investment For The Future 1/7/2015
Addex Therapeutics (ADXN.SW) And NIAAA Enter Collaboration To Evaluate ADX71441 In Alcohol Use Disorder 1/7/2015
Swedish Orphan Biovitrum Extends And Restructures Distribution Agreement With Exelixis, Inc. (EXEL) For Cometriq 1/7/2015
AstraZeneca PLC (AZN), GlaxoSmithKline (GSK) Turn to Crowd-Funding Experiment to Reinvigorate Slumping Pipeline 1/6/2015
Vectura Group plc (VEC.L) Signs Global Development And Licence Agreement With Janssen Biotech Inc. (JNJ) In Asthma/COPD 1/6/2015
TxCell, Ferring B.V. Strike €75 Million Plus Deal 1/2/2015
Tikcro Technologies Signs Research And License Agreement Regarding Cancer Immune Checkpoint Antibodies 12/30/2014
Ariad Pharmaceuticals, Inc. (ARIA) Announces Commercialization Agreement For Iclusig In Seven Central And Eastern European Countries 12/30/2014
OncoGenex Pharmaceuticals Inc. (OGXI) Snags $27 Million and Prostate/Lung Cancer Rights From Teva Pharmaceutical Industries Limited (TEVA) 12/30/2014
Gilead Sciences, Inc. (GILD), Johnson & Johnson (JNJ) Expand Existing HIV R&D Pact 12/29/2014
PPD, Inc. (PPDI) And Shin Nippon Biomedical Laboratories Announce Japanese Clinical Development Joint Venture And Additional Collaborations 12/29/2014
AMAG Pharmaceuticals, Inc. (AMAG), Takeda (TKPYY) Abandon $280 Million Ferumoxytol Pact 12/29/2014
BioLineRx Ltd. Out-Licenses Novel Skin Lesion Treatment To Omega Pharma 12/24/2014
Therapix Enters Strategic Collaboration For Development And Commercialization Of Oral Anti-CD3 Antibody In China 12/23/2014
Phylogica Ltd. Grabs $142 Million Deal With Genentech (RHHBY) 12/22/2014
Micron And A*STAR Data Storage Institute Renew Research Collaboration 12/22/2014
Protein Sciences Corporation, UMN Pharma And IHI Corporation Enter Into An Agreement To Evaluate Sourcing Flublok® From Japan 12/22/2014
Eddingpharm To Market Afib Drug In China For Cardiome Pharma Corp. (COM.TO) 12/22/2014
Weijian Pharma To Market Infertility Drug In China For LG Life Sciences, Ltd. 12/22/2014
Vernalis PLC (VNLPY.PK) Stumbles As Novartis AG (NVS) Abandons Work On AUY922 12/19/2014
Vernalis PLC (VNLPY.PK): Update On AUY922 Development Programme 12/19/2014
Achievement Of Multiple Milestones In Evotec AG (EVTG.F)'s Drug Discovery Alliances 12/19/2014
Oncodesign SA Has Entered Into A Services Agreement With Eisai Inc. (ESALF.PK) To Develop A New Personalized Medicine Program In Earlier Line Metastatic Breast Cancer Treatment 12/17/2014
Addex Therapeutics (ADXN.SW) Amends mGlu2PAM Collaboration Agreement And Receives USD757,000 12/17/2014
Generex Biotechnology Corporation (GNBT) Announces Participation In MedCannAccessCannScience Partnership On Non-Smoked Forms Of Marijuana 12/17/2014
Orexo AB (ORXOF) Receives Million 5£ Milestone Payment For Abstral® In Europe And Zubsolv® Continues Strong Market Share Growth In The US 12/17/2014
Lightlake Therapeutics Inc. (LLTP), Adapt Pharma Forge Deal Worth $55 Million 12/16/2014
Johnson & Johnson (JNJ) Pulls Out Of Program To Develop Bowel Disease Drug 12/16/2014
Regeneron (REGN), Sanofi (SAN.PA) Test The Public's Cholesterol IQ To Prep For Alirocumab Launch 12/16/2014
Foamix Pharmaceuticals, Ltd. (FOMX) Earns $2.5 Million Milestone Payment From Bayer HealthCare (BAY) 12/16/2014
CMC Biologics And OncoSynergy Enter Into An Agreement For Accelerated Process Development And GMP Manufacture Of An Investigational Drug To Combat Ebola 12/16/2014
Aseptix Signs Global Technology License With Ecolab Inc. (ECL) 12/16/2014
Carlina Technologies Signs A Partnership Agreement With Atlangram To Develop Controlled-Release Forms Of Antibiotics Targeting Osteoarticular Diseases 12/16/2014
Anthera Pharmaceuticals, Inc. (ANTH) Licenses Japan Rights For Blisibimod To Zenyaku Kogyo 12/15/2014
GE Healthcare Life Sciences Joins SBC's Neurodegenerative Disease Challenge 12/15/2014
Luqa Pharmaceuticals In-licenses Novel Wound Product From Histocell 12/10/2014
Pfizer (PFE) Grabs Rights To Preclinical Drugs From Startup In $29 Million+ Deal 12/9/2014
Leading Bone Repair Company BoneSupport And Regenerative Medicine Company Orthocell Announce A Heads Of Agreement 12/8/2014
SYGNIS AG Signs Initial Non-Exclusive Distribution Agreement For Its First Proprietary Product With BioCat GmbH 12/8/2014
Easton Pharmaceuticals (OP: EAPH) Announces Positive Updates, Changes To Its OTC Therapeutic Products, Manufacturing And North American Distributorship 12/8/2014
GE Healthcare Life Sciences Release: Licenses CRISPR Gene Engineering Technology Patents From Broad Institute 12/4/2014
Evotec AG (EVTG.F) Seals $310M Research Deal; Acquires Sanofi (SAN.PA)'s Toulouse Operations 12/4/2014
Garmatex Technologies, Inc. Release: New Partnership Aims To Produce Innovative Healthcare Products To Prevent The Spread Of Deadly Illnesses In Hospitals 12/3/2014
Nexvet Announces Collaboration And Distribution Agreement With Virbac 12/3/2014
Astellas Pharma Inc. (ALPMY), Janssen Biotech Inc. (JNJ) To End Collaboration On RA Drug ASP015K 12/2/2014
BioVersys AG And Enamine Ltd. Announce Extension Of Drug Discovery Collaboration To Address Multidrug-Resistant Bacterial Infections 12/2/2014
Nuvilex (NVLX) Obtains Exclusive Worldwide License To Develop Disease Treatments That Combine Cell-In-A-Box(R) And Cannabinoid-Based Medicine 12/2/2014
GeNeuro, Servier Ink $455M MS Drug Pact 12/2/2014
Mylan Inc. (MYL), Gilead Sciences, Inc. (GILD) Ink Agreement Covering Non-Exclusive TAF Rights 12/1/2014
Sanofi (SAN.PA), Pozen, Inc. (POZN) Terminate U.S. License Agreement For Gastric Ulcer Drugs 12/1/2014
Dynavax Technologies Corporation (DVAX) Regains Full Rights To Investigational TLR 7/9 Inhibitor DV1179 Following Expiration Of Collaboration With GlaxoSmithKline (GSK) 12/1/2014
AEterna Zentaris (AEZS) And Sinopharm A-Think Sign Master Collaboration Agreement For Zoptarelin Doxorubicin In China 12/1/2014
HanAll BioPharma Co., Ltd. (009420.KS) And Open Monoclonal Technology Announce Collaboration 12/1/2014
Nordic Nanovector And Affibody Collaborate On Advanced Radio-Immunotherapies Program For Multiple Myeloma 12/1/2014
Flamel Technologies (FLML) Sells Development And Manufacturing Facility In Pessac, France To Recipharm AB 12/1/2014
IP Group plcModern Biosciences plc Announces Collaboration Worth Up To £176m With Johnson & Johnson (JNJ) Innovation And Janssen Biotech Inc. (JNJ) 12/1/2014
flutiform® Launched In Spain; Abriff® Launched In Italy SkyePharma Inc. (SKYE) To Receive €2 Million Milestone From Mundipharma International Limited 12/1/2014
nanoPET Pharma Initiates R&D Partnership With Boehringer Ingelheim Corporation 12/1/2014
Nordic Nanovector And Affibody Collaborate On New Advanced Radio-Immunotherapies Program For Multiple Myeloma 11/26/2014
$1 Billion Oncology Alliance Between Menarini Group & Oxford BioTherapeutics Initiates First-In-Human Study Of Enhanced Antibody For Treatment Of Acute Myeloid Leukemia 11/25/2014
MRC Technology And Yabao Pharmaceuticals Announce Exclusive Partnership In China To Develop Novel Therapeutics For Parkinson’s Disease 11/24/2014
GlaxoSmithKline (GSK) Shareholders To Vote On Novartis AG (NVS) Deal On Dec. 18 11/24/2014
Trimel Pharmaceuticals (TRL.TO), Endo International (ENDP) Ink NATESTO Deal For Up To $195M 11/24/2014
Camurus, Braeburn Pharmaceutical Ink Licensing Deal Worth Up To $151 Million 11/21/2014
Yabao Pharmaceuticals And MRC Technology Announces Exclusive China Partnership 11/21/2014
Sunshine Biopharma, Inc. Signs Agreement With Lonza Biologics Inc. (LONN.VX) To Manufacture Its Lead Anti-Cancer Compound, Adva-27a 11/20/2014
Ipsen (IPN.PA) And CNRS Create The "Archi-Pex" Joint Research And Innovation Lab, In Collaboration With The University Of Rennes 1 And CEA 11/20/2014
Ikaria Inc. And Lee's Pharmaceutical Announce Strategic Partnership For The Registration And Commercialization Of Ikaria's INOMAX Total Care Package In The People's Republic Of China, Hong Kong, Macau And Taiwan 11/19/2014
3SBio Inc. (SSRX) Signs Exclusive Patent License Agreement For Tanibirumab, An Anti-VEGFR2/KDR Mab With Pharmabcine 11/18/2014
MiNA Completes Exclusive License Agreement With University of California, San Francisco (UCSF) 11/18/2014
Omnicell And King Faisal Specialist Hospital And Research Centre Collaborate To Deliver Excellence In Automation 11/18/2014
Generex Biotechnology Corporation (GNBT) Announces Collaboration On Medicinal Cannabis 11/18/2014
MYMETICS Corporation Announces New Collaboration To Advance The Development Of An Innovative Malaria Vaccine Candidate 11/18/2014
A*STAR’s Genome Institute of Singapore Strengthens Its Genome Sequencing Capabilities Through Collaboration With BT 11/18/2014
Pfizer (PFE), Merck KGaA (MKGAF.PK) Strike A $2.9B Deal To Develop Cancer Tumor Treatment 11/18/2014
Baring Asia Says Agrees To Buy Japan Drugmaker Bushu From Tokio Marine 11/17/2014
Cardiome Pharma Corp. (COM.TO) Enters Commercialization Agreement With Aspen For BRINAVESS® In South Africa 11/17/2014
Bone Therapeutics & Kasios Collaborate On Novel Product For Optimisation Of Spinal Fusion Procedures 11/17/2014
Merz Pharma Canada Ltd. Announces Exclusive Distribution Arrangement With Ulthera 11/17/2014